摘要
目的:研究黑色素瘤相关抗原基因-D4(MAGE-D4)和细胞分裂周期蛋白25A(CDC25A)在人脑胶质瘤(胶质瘤)中的表达水平和临床意义,并探究二者的关系。方法:利用GEPIA在线数据库分析胶质瘤组织中MAGE-D4和CDC25A的表达情况,然后收集47例胶质瘤组织,逆转录实时荧光定量聚合酶链反应(PT-qPCR)验证MAGE-D4和CDC25A的表达,并进一步统计分析其与临床病理指标的关系及二者表达相关性。结果:GEPIA数据库显示MAGE-D4与CDC25A在胶质瘤组织中均高表达(P<0.05);PT-qPCR结果显示所检测的胶质瘤组织MAGE-D4 mRNA和CDC25A mRNA的表达水平均明显高于正常脑组织,且二者表达呈明显正相关关系(r=0.3174,P<0.05);此外,MAGE-D4 mRNA的表达与WHO分级和Ki-67表达相关,而CDC25A mRNA表达仅与WHO分级相关(P<0.05)。结论:CDC25A与MAGE-D4在胶质瘤组织中呈正相关关系,提示二者可能共同在胶质瘤的发生发展中发挥重要作用,可能成为胶质瘤生物治疗的潜在靶点。
Objective: To study the expression level and clinical significance of melanoma associated antigen geneD4(MAGE-D4)and mitotic cyclin 25 A(CDC25 A)in human gliomas,and to explore their relationship.Methods:The expression of MAGE-D4 and CDC25 A in glioma tissues were analyzed by GEPIA online database.Then 47 glioma tissues were collected,and the expression of MAGE-D4 and CDC25 A were verified by reversr transcriptase real-time fluirescent polymerase chain reaction(PT-qPCR).The correlation of MAGE-D4,CDC25 A,and clinical pathological indexes were analyzed.Results: GEPIA database showed that both MAGE-D4 and CDC25 A were highly expressed in glioma tissues(P<0.05).qPCR showed that the expression levels of MAGE-D4 mRNA and CDC25 A mRNA in glioma tissues were significantly higher than those in normal brain tissues,and there was a significant positive correlation between MAGE-D4 mRNA and CDC25 A mRNA expression(r=0.3174,P<0.05).In addition,the expression of MAGE-D4 mRNA was correlated with WHO grade and Ki-67 expression,while the expression of CDC25 A mRNA was only correlated with WHO grade(P<0.05).Conclusion: There is a positive correlation between CDC25 A and MAGE-D4 in glioma tissue,which suggests that both of them may play an important role in the occurrence and development of glioma and may become potential targets for glioma biotherapy.
作者
张之碧
张庆梅
刘畅
罗鑫
罗彬
葛盈盈
陈芳
沈宁
肖绍文
谢小薰
Zhang Zhibi;Zhang Qingmei;Liu Chang;Luo Xin;Luo Bin;Ge Yingying;Chen Fang;Shen Ning;Xiao Shaowen;Xie Xiaoxun(Department of Histology and Embryology,Guangxi Medical University,Nanning 530021,China;Key Laboratory of Basic Medical Research,Guangxi Medical University,Nanning 530021,China;Department of Neurosurgery,The First Affiliated Hospital of Guangxi Medical University,Nanning 530021,China;Department of Oral and Maxillofacial Surgery,The People’s Hospital of Guangxi Zhuang Autonomous Region,Nanning 530021,China)
出处
《广西医科大学学报》
CAS
2020年第4期640-644,共5页
Journal of Guangxi Medical University
基金
国家自然科学基金项目资助(No.81560408,81460382,81960453,81860445)
广西自然科学基金资助项目(No.2017GXNSFAA198001,2018GXNSFAA050058)
广西区域性高发肿瘤早期防治研究教育部重点实验室课题资助项目(No.K2015-TKF03,NO.GK2018-09,No.GKE2019-08)
广西高校中青年教师基地能力提升项目(No.2018KY0109)。